Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis - PubMed (original) (raw)

Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis

A A Quyyumi et al. J Clin Invest. 1995 Apr.

Abstract

The bioavailability of nitric oxide (NO) in the human coronary circulation at rest and after acetylcholine (ACH)-induced vasodilation was investigated in 32 patients with angiographically normal coronary arteries. The effects of intracoronary L-NG monomethyl arginine (L-NMMA) were investigated at rest and after ACH, sodium nitroprusside, and adenosine. L-NMMA (64 mumol/min) increased resting coronary vascular resistance by 22% (P < 0.001), reduced distal epicardial coronary artery diameter by 12.6% (P < 0.001), and inhibited ACH-induced coronary epicardial and microvascular vasodilation. These effects were reversed with intracoronary L-arginine. L-NMMA did not inhibit dilation in response to sodium nitroprusside and adenosine. 23 patients were exposed to one or more coronary risk factors. The vasoconstrictor effect of L-NMMA on the epicardial and microvessels was greater in patients free of risk factors: Coronary vascular resistance was 36% higher in patients without risks, compared to 17% higher in patients with risks (P < 0.05). Both epicardial and microvascular dilator effects of ACH were greater in patients without risk factors, and the inhibition of these effects by L-NMMA was also greater in patients without risk factors. Thus: (a) NO contributes importantly to resting epicardial and coronary microvascular tone, (b) coronary vascular dilation in response to ACH is predominantly due to increased production of NO, and (c) despite the absence of angiographic evidence of atherosclerosis, exposure to coronary risk factors is associated with reduced resting and stimulated bioavailability of NO from the human coronary circulation.

PubMed Disclaimer

Similar articles

• Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
  Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO 3rd. Quyyumi AA, et al. Circulation. 1995 Aug 1;92(3):320-6. doi: 10.1161/01.cir.92.3.320. Circulation. 1995. PMID: 7634444 Clinical Trial.
• Nitric oxide activity in the atherosclerotic human coronary circulation.
  Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO 3rd. Quyyumi AA, et al. J Am Coll Cardiol. 1997 Feb;29(2):308-17. doi: 10.1016/s0735-1097(96)00472-x. J Am Coll Cardiol. 1997. PMID: 9014982
• Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
  Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Lefroy DC, et al. Circulation. 1993 Jul;88(1):43-54. doi: 10.1161/01.cir.88.1.43. Circulation. 1993. PMID: 8319355
• L-Arginine in coronary atherosclerosis.
  Tentolouris C, Tousoulis D, Goumas G, Stefanadis C, Davies G, Toutouzas P. Tentolouris C, et al. Int J Cardiol. 2000 Sep 15;75(2-3):123-8. doi: 10.1016/s0167-5273(00)00320-x. Int J Cardiol. 2000. PMID: 11077122 Review.
• Skin microcirculation in healthy subjects and patients with arteriosclerosis.
  Wenzel RR, Bruck H, Baumgart D, Oldenburg O, Erbel R, Philipp T. Wenzel RR, et al. Herz. 1999 Nov;24(7):576-80. doi: 10.1007/BF03044229. Herz. 1999. PMID: 10609164 Review.

Cited by

• Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus.
  Chen S, Shen Y, Liu YH, Dai Y, Wu ZM, Wang XQ, Yang CD, Li LY, Liu JM, Zhang LP, Shen WF, Ji R, Lu L, Ding FH. Chen S, et al. Cardiovasc Diabetol. 2021 Mar 13;20(1):64. doi: 10.1186/s12933-021-01257-y. Cardiovasc Diabetol. 2021. PMID: 33714276 Free PMC article.
• Assessment of endothelial function by means of flow-mediated changes using pulse wave velocity.
  Rusak EJ, Bellido CA, Iavicoli OR, Vazquez ST, Duarte M, Lerman J. Rusak EJ, et al. J Clin Hypertens (Greenwich). 2010 Jul 1;12(7):495-501. doi: 10.1111/j.1751-7176.2010.00292.x. J Clin Hypertens (Greenwich). 2010. PMID: 20629811 Free PMC article.
• First evaluation of real-time nitric oxide changes in the coronary circulation in patients with non-ischaemic dilated cardiomyopathy using a catheter-type sensor.
  Takarada S, Imanishi T, Goto M, Mochizuki S, Ikejima H, Tsujioka H, Kuroi A, Takeshita T, Akasaka T. Takarada S, et al. Eur Heart J. 2010 Dec;31(23):2862-70. doi: 10.1093/eurheartj/ehq156. Epub 2010 May 28. Eur Heart J. 2010. PMID: 20511328 Free PMC article.
• Endothelial dysfunction in patients with ankylosing spondylitis.
  Łosińska K, Korkosz M, Kwaśny-Krochin B. Łosińska K, et al. Reumatologia. 2019;57(2):100-105. doi: 10.5114/reum.2019.84815. Epub 2019 Apr 29. Reumatologia. 2019. PMID: 31130748 Free PMC article. Review.
• [Therapeutic options for improvement of myocardial perfusion in coronary atherosclerosis].
  Schächinger V. Schächinger V. Herz. 1998 Mar;23(2):116-29. doi: 10.1007/BF03044542. Herz. 1998. PMID: 9592707 Review. German.

References

1. 1. Br J Pharmacol. 1989 Feb;96(2):418-24 - PubMed
2. 1. J Pharmacol Exp Ther. 1982 Jul;222(1):166-73 - PubMed
3. 1. Nature. 1983 Oct 13-19;305(5935):627-30 - PubMed
4. 1. J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1161-9 - PubMed
5. 1. N Engl J Med. 1986 Oct 23;315(17):1046-51 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • American Society for Clinical Investigation
  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database